Results 131 to 140 of about 83,617 (230)

Development of novel alpha 2B adrenergic receptor ligands by using a palladium catalyzed Buchwald Hartwig amination with a brominated benzodiazepine. [PDF]

RSC Med Chem
Fernando MRT, Vincent AB, Harrington SG, Toriola MA, Medubi KM, Meyer MJ, Webb DA, Arnold LA.   +7 more
europepmc   +1 more source

Agmatine decreases long-term potentiation <i>via</i> α2-adrenergic receptor and imidazoline type 1 receptor in the hippocampus. [PDF]

Korean J Physiol Pharmacol
Chang W, An J, Jang SH, Kim M, Min SS.
europepmc   +1 more source

Advances in the treatment of malignant tumors with neurological drugs. [PDF]

Discov Oncol
Li Y, Na J, Zhong L, Zhao Y.
europepmc   +1 more source

β₂-Adrenergic Receptor Agonists in Diabetic Kidney Disease: Exploring a New Frontier. [PDF]

Biochem Res Int
Hegde S, Chogtu B, Magazine R, Magazine R, Prabhu R.   +4 more
europepmc   +1 more source

Neurotransmitter signaling in white matter [PDF]

, 2014
Butt, Arthur M., Fern, Robert F., Matute, Carlos   +2 more
core   +1 more source

Expression Dynamics of Neurotransmitter System Genes in Early Sea Urchin Embryos: Insights from a Four-Species Comparative Transcriptome Analysis. [PDF]

Biology (Basel)
Shmukler YB, Alyoshina NM, Nikishina YO, Nikishin DA.   +3 more
europepmc   +1 more source

Role of TRPV1 in neuroendocrine regulation: a potential target against obesity? [PDF]

Front Immunol
Wang J, Liu M, Wen L, Xing P, Chen J, Xia X, Ding W.   +6 more
europepmc   +1 more source

Changes in .ALPHA.-adrenergic receptors in rat brain in vitro by preincubation with .ALPHA.-adrenergic ligands.

The Japanese Journal of Pharmacology, 1980
Hajime Ishida, Fumiaki Hata, Kunio Takeyasu, Shuji Uchida, Hiroshi Yoshida   +4 more
openaire   +4 more sources

Paliperidone Palmitate Toxicity in Chronic Kidney Disease: A Case of Life-Threatening Autonomic Failure. [PDF]

Cureus
Rishu R, Abdallah A, Pandit D.
europepmc   +1 more source